Retinopathy of Prematurity

Overview

Retinopathy of Prematurity (ROP) is a potentially blinding eye condition that affects premature infants. It occurs when abnormal blood vessels grow in the retina, the light-sensitive layer at the back of the eye. ROP is more common in infants born before 31 weeks of gestation or weighing less than 1.25 kg at birth. Early diagnosis and treatment are critical to prevent vision loss.

Routinely performed procedures

  1. Screening: Premature infants at risk are regularly examined by an ophthalmologist using an ophthalmoscope to assess retinal development.
  2. Diagnosis: The stage and severity of ROP are determined based on the extent of abnormal blood vessel growth in the retina.
  3. Laser Therapy: For moderate to severe cases, laser treatment stops abnormal blood vessel growth by targeting the peripheral retina.
  4. Anti-VEGF Injections: In certain cases, medications are injected into the eye to inhibit abnormal blood vessel formation.
  5. Surgical Intervention: For advanced ROP (Stage 4 or 5), procedures like scleral buckling or vitrectomy may be required to prevent retinal detachment.
  6. Follow-Up: Regular post-treatment examinations ensure proper healing and monitor for recurrence of abnormal vessel growth
 

Frequently Asked Questions!

ROP is caused by abnormal growth of blood vessels in the retina, often triggered by incomplete development due to premature birth.

ROP is detected through regular retinal screenings using a special instrument to examine the eye’s back in premature infants.

While ROP cannot be entirely prevented, timely screening, oxygen level management, and early treatment can significantly reduce the risk of severe outcomes.

Treatment options include laser therapy, anti-VEGF injections, or surgery, depending on the severity of the condition.

If treated early, many infants recover well, but severe cases may lead to permanent vision impairment or blindness despite treatment. Regular follow-ups are crucial.